UMOD and kidney disorder: These results not only underscore the crucial involvement of TMED cargo-receptors in the molecular mechanisms underlying UMOD-associated kidney pathologies but also highlight pharmacological targeting of these receptors as a promising therapeutic strategy for addressing kidney disease triggered by aberrant UMOD trafficking.